IBEX vs PATH · P/E 13, rev $558.3M vs P/E 19, rev $1.61B
IBEX Ltd (IBEX) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
IBEX Ltd (IBEX) is a information technology services company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported IBEX revenue for 2025-06-30 was $558.3M. Net income was $36.9M. Revenue was up 9.8% from 2024-06-30 to 2025-06-30. IBEX currently screens at market cap $388.5M and trailing P/E 12.9.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
IBEX currently screens at market cap $388.5M and trailing P/E 12.9. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the IBEX and PATH stock pages for the full models.
Not investment advice.